Do not mask your child

Do not mask your child

Let’s Start this Interesting Article Shared on

Tell me one thing
Warning: Do not mask your child
  • A research by a Japan-based medical group has warned parents to apply face masks on their children, who may be younger than 2 years old, as it may be. Face risk or suffocate them. According to the Japan Pediatric Association, “Masks can make breathing difficult because infants have narrow airways” – this not only puts a greater burden on the heart of infants, but also increases the risk of heatstroke.
  • According to the association, the prevalence of Kovid-19 among children has been limited, with very few serious cases – in fact, most children who had become infected infected the infection from family members as most schools or day care facilities closed. Which prevented any outbreak. there. As a warning to the association, Japan had lifted the state of emergency in view of the spread of Kovid-19.
  • Even the American Centers for Disease Control and Prevention (CDC) strongly Recommend applying face mask on children Less than 2 years. In addition to the risk of suffocation, the US CDC also notes that children touch their face more often, which will not only negate the usefulness of a face mask, but may actually increase the risk of having any virus residue on the mask needed.
  • The Ministry of Health of India has confirmed 145,380 Kovid-19 cases (80,722 active cases) and 4,167 fatal cases. 6,535 fresh cases were reported on Monday.
  • There are 346,306 fatalities (approximately 5.5 million infections) worldwide.

Number is 12:30 IST on Tuesday. See the latest data here

today have
What is wrong with Gujarat’s Kovid model?
What is wrong with Gujarat's Kovid model?
Gujarat, which has reported 14,000 Kovid-19 cases and deaths of over 888 people – the second after Maharashtra – is facing heat over its decision to limit testing. The Ahmedabad Medical Association (AMA) has threatened to go on strike if the state government did not withdraw its notification to private hospitals to seek approval from nodal officers to conduct Kovid-19 tests on patients undergoing surgery or critical care. Will have to get approval, report Ahmedabad Mirror. AMA President Dr. “These patients can become potential super spreaders if they are found positive at late stage,” said Mona Desai.

The Ahmedabad Hospitals and Nursing Home Association (AHNHA) has also raised objections. In a sharp words, AHNHA sought to know “Whose decision is it to ban the test?” “A single authority will be responsible for its disastrous consequences,” Warned it. “Even for non-Kovid treatments, we need to pre-rule Kovid to avoid complications later and protect our employees from contracting the virus. Looking at the guidelines issued by the state government, it has become a challenge for us, “Dr. Bharat Gadhvi, President, Ahmed told Economic Times.

according to Mirror, Gujarat is testing between 7, 500 and 500 to 500 in a day. But experts say the possibility of delays in special approvals of patients admitted to hospitals is being explored, potentially losing important days. Delayed identification has been a concern in the state. On 23 April, times of India The report says that Gujarat detects delayed cases of infection cycles, with data on fatal incidents reported within two days of testing.

A few days after the Gujarat High Court criticized the state government for not doing enough tests, the fact has come out that “the argument that ‘greater numbers of tests, which lead to 70% of the population test positive for Kovid’, Fear can lead to psychosis ‘there is a basis for denial or prohibition of trial’. The Gujarat government has now sought “clarification” on the court’s order.

Gujarat’s troubles are beyond trial. Last week, Ahmedabad Civil Hospital came into the limelight for its unusually high mortality rate – by 19 May, 343 Kovid-19 patients had died in the hospital, 338 recovered. The state government, in a letter after the civil hospital, also questioned whether the ventilators were developed by a private firm based in Rajkot Not even mark.

Be safe
Before you dive this summer
Before you dive this summer
  • The American Center for Disease Control and Prevention says there is no evidence that SARS-can spread to humans via nCoV-2 Swimming pool access. The CDC stated, “The pool’s chlorine and bromine must be removed or inactivated with viruses that cause proper operation, maintenance, and disinfection (eg, Kovid-19).”
  • Ernest Bletchley III, a professor of environmental and ecological engineering at Purdue University in West Lenfette, said there was no data to show how coronoviruses react to chlorine. “But we know that chlorine effectively inactivates similar viruses,” he said. The general guidance for properly disinfecting the pool is maintaining a free chlorine concentration between 1–5 mg per liter. If a pool contains that concentration, then there are very few infectious novel coronaviruses in the water, ”he explained.
  • KA Bidley, a professor of microbial oceanography at Rutgers University, does not think the virus will survive very well in water, or that it will spread quickly to a body of water, and so it is unlikely that you will be infected that way.
  • But health officials still recommend staying at least 6 feet away from others because Kovid-19 is a respiratory disease. In other words, you probably have not obtained coronovirus from water, but you can get coronavirus from someone close to you in water.
Lockdown Doubt? We are here to help you! Send us all your questions related to lockdown here times of India Will seek answers from concerned authorities and include a select few in the newspaper.
Good News
Studies and experiments for a Kovid-19 treatment
Studies and experiments for a Kovid-19 treatment
  • More than 50 clinical trials of the Kovid-19 vaccine have started in India, Report ET. This is different from the World Health Organization solidarity test that started in India for drug combinations such as lopinavir + ritonavir, remedisvir and interferon beta-LA. While it is not yet known what the winning drug or drugs will look like, the top three treatment options being studied in India use hydroxychloroquine (HCQ), plasma therapy, and the BCG vaccine.
  • Despite controversial data coming from observational studies on its efficacy, HCQ is being studied in more than 20 registered trials. The WHO on Monday halted the HCQ Solidarity trial.
  • Convulsive plasma therapy leads in the number of registered trials. There are 10 studies at 17 centers in India.
  • The 80-year-old BCG vaccine is in the queue – three trials are in the country to see if the BCG vaccine and its modification recombinant BCG Kovid-19 work on the safety of health workers involved in duty as well as patients. .
  • Also under study is the anti-cancer drug imatinib, which has shown efficacy in the laboratory for diseases such as MERS and SARS corona.
Call time
Your state or union territory has a list of helpline numbers. here
Live update here
Follow the news that matters to you in real time.
Join 30 million news enthusiasts

written by: Rakesh Rai, Judhajit Basu, Sumit Sudhakaran, Tejesh N.S. Behl
The research: Rajesh Sharma


Leave a Reply

Your email address will not be published. Required fields are marked *